Prognostic relevance of estrogen receptor α, β and aromatase expression in non-small cell lung cancer

[1]  J. J. Li,et al.  Hormonal Carcinogenesis , 2020, Springer New York.

[2]  E. Richardsen,et al.  The prognostic role of progesterone receptor expression in non-small cell lung cancer patients: Gender-related impacts and correlation with disease-specific survival , 2015, Steroids.

[3]  H. Kalofonos,et al.  The inhibition of aromatase alters the mechanical and rheological properties of non-small-cell lung cancer cell lines affecting cell migration. , 2015, Biochimica et biophysica acta.

[4]  Jessica Lo,et al.  Structural basis for the functional roles of critical residues in human cytochrome p450 aromatase. , 2013, Biochemistry.

[5]  J. Dering,et al.  Antiestrogen Fulvestrant Enhances the Antiproliferative Effects of Epidermal Growth Factor Receptor Inhibitors in Human Non–Small-Cell Lung Cancer , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[6]  H. Sasano,et al.  Co-expression of estrogen receptor beta and aromatase in Japanese lung cancer patients: gender-dependent clinical outcome. , 2012, Life sciences.

[7]  S. Horvath,et al.  Expression levels of estrogen receptor beta in conjunction with aromatase predict survival in non-small cell lung cancer. , 2011, Lung cancer.

[8]  R. Dhir,et al.  Combined Analysis of Estrogen Receptor β-1 and Progesterone Receptor Expression Identifies Lung Cancer Patients with Poor Outcome , 2010, Clinical Cancer Research.

[9]  Takashi Suzuki,et al.  Intratumoral localization of aromatase and interaction between stromal and parenchymal cells in the non-small cell lung carcinoma microenvironment. , 2010, Cancer research.

[10]  P. Lønning.  The potency and clinical efficacy of aromatase inhibitors across the breast cancer continuum , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[11]  J. Siegfried,et al.  Estrogen receptor beta (ERβ) subtype-specific ligands increase transcription, p44/p42 mitogen activated protein kinase (MAPK) activation and growth in human non-small cell lung cancer cells , 2009, The Journal of Steroid Biochemistry and Molecular Biology.

[12]  M. Fishbein,et al.  Targeting Aromatase and Estrogen Signaling in Human Non‐Small Cell Lung Cancer , 2009, Annals of the New York Academy of Sciences.

[13]  J. Crowley,et al.  The revised TNM staging system for lung cancer. , 2009, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

[14]  D. Edwards,et al.  The role and mechanism of progesterone receptor activation of extra-nuclear signaling pathways in regulating gene transcription and cell cycle progression , 2008, Steroids.

[15]  Takashi Suzuki,et al.  Intratumoral Estrogens and Estrogen Receptors in Human Non–Small Cell Lung Carcinoma , 2008, Clinical Cancer Research.

[16]  S. Badve,et al.  Estrogen promotes tumor progression in a genetically defined mouse model of lung adenocarcinoma. , 2008, Endocrine-related cancer.

[17]  T. Dønnem,et al.  Inverse Prognostic Impact of Angiogenic Marker Expression in Tumor Cells versus Stromal Cells in Non–Small Cell Lung Cancer , 2007, Clinical Cancer Research.

[18]  I. Wistuba,et al.  Aromatase expression predicts survival in women with early-stage non small cell lung cancer. , 2007, Cancer research.

[19]  Margaret Warner,et al.  Estrogen receptors: how do they signal and what are their targets. , 2007, Physiological reviews.

[20]  M. Fishbein,et al.  Estrogen receptor signaling pathways in human non-small cell lung cancer , 2007, Steroids.

[21]  Robert Gray,et al.  Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. , 2006, The New England journal of medicine.

[22]  M. Fishbein,et al.  Aromatase inhibitors in human lung cancer therapy. , 2005, Cancer research.

[23]  H. Pass,et al.  Nuclear Estrogen Receptor β in Lung Cancer: Expression and Survival Differences by Sex , 2005, Clinical Cancer Research.

[24]  J. Gustafsson,et al.  Estrogen receptors alfa (ERα) and beta (ERβ) differentially regulate proliferation and apoptosis of the normal murine mammary epithelial cell line HC11 , 2005, Oncogene.

[25]  S. Bulun,et al.  Regulation of Aromatase Expression in Estrogen-Responsive Breast and Uterine Disease: From Bench to Treatment , 2005, Pharmacological Reviews.

[26]  Takashi Suzuki,et al.  Progesterone receptor in non-small cell lung cancer--a potent prognostic factor and possible target for endocrine therapy. , 2005, Cancer research.

[27]  Hideki Kawai,et al.  Estrogen Receptor α and β are Prognostic Factors in Non–Small Cell Lung Cancer , 2005, Clinical Cancer Research.

[28]  M. Fishbein,et al.  Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells , 2005, Steroids.

[29]  J. Siegfried,et al.  Combined targeting of the estrogen receptor and the epidermal growth factor receptor in non-small cell lung cancer shows enhanced antiproliferative effects. , 2005, Cancer research.

[30]  S. Gabriel,et al.  EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy , 2004, Science.

[31]  Takashi Suzuki,et al.  The human CYP19 (aromatase P450) gene: update on physiologic roles and genomic organization of promoters , 2003, The Journal of Steroid Biochemistry and Molecular Biology.

[32]  E. Gabrielson,et al.  High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  J. Luketich,et al.  Human Non-Small Cell Lung Tumors and Cells Derived from Normal Lung Express Both Estrogen Receptor α and β and Show Biological Responses to Estrogen , 2002 .

[34]  Mike Clarke,et al.  Tamoxifen for early breast cancer: an overview of the randomised trials , 1998, The Lancet.

[35]  K. Korach,et al.  Tissue Distribution and Quantitative Analysis of Estrogen Receptor-α (ERα) and Estrogen Receptor-β (ERβ) Messenger Ribonucleic Acid in the Wild-Type and ERα-Knockout Mouse. , 1997, Endocrinology.

[36]  Y. Ito,et al.  Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. , 1994, Endocrine reviews.

[37]  A. Jemal,et al.  Cancer statistics, 2015 , 2015, CA: a cancer journal for clinicians.

[38]  W. Travis.  WHO classification of tumours of the lung, pleura, thymus and heart , 2015 .

[39]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.